Co-Authors
This is a "connection" page, showing publications co-authored by Arda Kiani and Farzaneh Dastan.
Connection Strength
0.893
-
Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial. Int Immunopharmacol. 2020 Nov; 88:106869.
Score: 0.224
-
Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung. Iran J Allergy Asthma Immunol. 2020 May 17; 19(S1):10-12.
Score: 0.221
-
Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19. J Glob Antimicrob Resist. 2020 06; 21:340-341.
Score: 0.220
-
Combination therapy of IFNß1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients. Int Immunopharmacol. 2021 Mar; 92:107329.
Score: 0.058
-
Blood Purification Techniques, Inflammatory Mediators and Mortality in COVID-19 Patients. Tanaffos. 2020 Dec; 19(4):291-299.
Score: 0.057
-
NRITLD Protocol for the Management of Patients with COVID-19 Admitted to Hospitals. Tanaffos. 2020 Nov; 19(2):91-99.
Score: 0.057
-
Clinical Manifestations of Patients with Coronavirus Disease 2019 (COVID-19) in a Referral Center in Iran. Tanaffos. 2020 Nov; 19(2):122-128.
Score: 0.057